However, depletion of FSP1 alone was sufficient to suppress tumor growth in a xenograft model of lung cancer [98], raising the possibility that treatment with only FSP1 inhibitors may have therapeutic value for certain cancers in vivo. The gene discussed is AIFM2; the disease is lung carcinoma.